Home / Pharma Healthcare / In-depth Research Report of Global Transdermal Patch Market (2019 Version)

In-depth Research Report of Global Transdermal Patch Market (2019 Version)

  • Id : RNR-263683
  • Category : Pharma Healthcare
  • Publish Date : 19-Mar-19
  • Publisher : Lilan Data & Info
  • Pages : 134
  • Format : PDF
License Type

Description
The Report mainly includes sales, revenue, trade, competition, investment, forecast and marketing of the product and the segments here include companies, types, applications, regions, countries, etc. 

The Global  market of Transdermal Patch is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new LDI (Lilan Data & Info) study.

The regions of Transdermal Patch contain all Global  market, especially in North America, Europe, Asia Pacific, Latin America and MEA. 

Players include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, etc.

Types cover Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others, etc. and applications cover The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain., Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body., Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles., Others, etc.

There are 11 Chapters to deeply display the global Transdermal Patch market.
Chapter 1, is  definition and segment of Transdermal Patch;
Chapter 2, is executive summary of Transdermal Patch Market;
Chapter 3, to explain the industry chain of Transdermal Patch;
Chapter 4, to show info and data comparison of  Transdermal Patch Players;
Chapter 5, to show comparison of types;
Chapter 6, to show comparison of applications;
Chapter 7, to show comparison of regions and coutries(or sub-regions);
Chapter 8, to show competition and trade situation of Transdermal Patch Market;
Chapter 9, to forecast Transdermal Patch market in the next years;
Chapter 10, to show investment of Transdermal Patch Market;